Effect of methylenetetrahydrofolate reductase 677C→T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients

@article{Toffoli2003EffectOM,
  title={Effect of methylenetetrahydrofolate reductase 677C→T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients},
  author={G. Toffoli and A. Russo and F. Innocenti and G. Corona and S. Tumolo and F. Sartor and E. Mini and M. Boiocchi},
  journal={International Journal of Cancer},
  year={2003},
  volume={103}
}
  • G. Toffoli, A. Russo, +5 authors M. Boiocchi
  • Published 2003
  • Medicine
  • International Journal of Cancer
  • MTHFR is a critical enzyme that regulates the metabolism of folate and methionine, both of which are important factors in DNA methylation and synthesis. Subjects with the 677C→T variant have impaired remethylation of Hcy to methionine that could determine hyperhomocysteinemia. Remethylation of Hcy into methionine and DNA methylation are also affected by MTX treatment. Thus, a combined effect between MTX and reduced activity of the MTHFR 677C→T polymorphism could occur, leading to toxicity. In a… CONTINUE READING

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 35 REFERENCES